Publication | Closed Access

Dual-targeting daunorubicin liposomes improve the therapeutic efficacy of brain glioma in animals

Neuro-oncologyDrug TargetingBrain GliomaMedicineDual-targeting Daunorubicin LiposomesTherapeutic EfficacyTumor TargetingNeurologyHigh-grade GliomasAnti-cancer AgentPharmacologyGliomaTumor MicroenvironmentNeuroinflammation